期刊文献+

人格解体的原发性症状

原文传递
导出
摘要 人格解体的原发性症状包括外感觉减退、内感觉减退、出神、注意狭窄、回忆模糊、回忆缺失、思维模糊、思维缺失、情感缺失、言语自动化、动作自动化、灵魂模糊、灵魂缺失。
出处 《国际精神病学杂志》 2015年第2期126-129,共4页 Journal Of International Psychiatry
  • 相关文献

参考文献10

  • 1喻东山.人格解体的病因和治疗[J].国际精神病学杂志,2012,39(2):108-111. 被引量:2
  • 2Weiner E, McKay D. A preliminary evaluation of repeated ex- posure for depersonalization and derealization. Behav Modi 2013, 37 (2): 226-242.
  • 3Schoenberg PL, Sierra M, David AS. Psychophysiological in- vestigations in depersonalization disorder and effects of electro- dermal biofeedback. J Trauma Dissociation, 2012, 13 (3) : 311-329.
  • 4Aliyev NA, Aliyev ZN. Lamotrigine in the immediate treatment of outpatients with depersonalization disorder without psychiat- ric comorbidity : randomized, double - blind, placebo - con- trolled study. J Clin Psychopharmacol. 2011 , 31 ( 1 ) : 61 - 65.
  • 5Mantovani A, Simeon D, Urban N, et al. Temporo-parietal junction stimulation in the treatment of depersonalization disor-der. Psychiatry Res. 2011, 186 (1) : 138-140.
  • 6Jouregui-Renaud K, Sang FY, Gresty MA, et al. Depersonal- isatiort/derealisation symptoms and updating orientation in pa- tients with vestibular disease. J Neurol Neurosurg Psychiatry, 2008, 79 (3): 276-283.
  • 7Giesbrecht T, Smeets T, Merekelbach H, et al. Depersonali- zation experiences in undergraduates arerelated to heightened stress eortisol responses. J Nerv Ment Dis. 2007, 195 (4) : 282-287.
  • 8Sierra M, Baker D, Medford N, et al. Lamotrigine as an add -on treatment for depersonalization disorder: a retrospective study of 32 eases. Clin Neuropharmaeol. 2006, 29 (5) : 253 -258.
  • 9Sierra M, Gomez J, Molina J J, et al. Depersonalization in psychiatric patients: a transeuhural study. J Nerv Ment Dis. 2006, 194 (5): 356-361.
  • 10Simeon D, Knutelska M. An open trial of naltrexone in the treatment of depersonalization disorder. J Clin Psychopharma- col. 2005, 25 (3): 267-270.

二级参考文献8

  • 1Lemche E, Surguladze SA, Giampietro VP, et al. Limbic and prefrontal responses to facial emotion expressions in de- personalization . NeuroReport,2007 ; 18:473 - 477.
  • 2Mula M, Pini S, Cassano GB, et al. The neurobiology and clinical significance of depersonalization in mood and anxiety disorder:a critical reappraisal. J Affect Dis. 2007; 99:91 -99.
  • 3Sierra M. Depersonalization disorder:pharmacological approa- ches. Expert Rev Neurotherapeutics, 2008 ;8 ( 1 ) : 19 - 26.
  • 4Sierra M, David AS. Depersonalization : a selective impair- ment of self - awareness . Consciousness and Cognition, 2011 ;20:99 - 108.
  • 5Simeon D, Giesbrecht T, Knutelska M, et al. Alexithymia, absorption, and cognitive failures in depersonalization disor- der: comparison to posttraumatic stress disorder and healthy volunteers. J Nerv Ment Dis. 2009;197:482-498.
  • 6Mancini -Marie A, Fahim C, Potvin S, et al. Quetiapine : focus on emotional numbing in depersonalization disorder: an fMRI case report. Eur Psychiatry,2006 ;21:574 - 577.
  • 7Michal M, Beutal ME, Jordan J, et al. Depersonalization, mindfulness , and childhood trauma. J Nerv Ment Dis. 2007 ; 195:693 - 696.
  • 8Levin R, Sivof B, Simeon D, et al. Role of fantasy proneness , imaginative involvement , and psychological absorption in depersonalization disorder. J Nerv Ment Dis. 2004;192(1 ) : 69 -71.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部